Predictors of 30-day readmission and resource utilization after thoracic endovascular aortic repair
- 1 September 2020
- journal article
- conference paper
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 58 (3), 574-582
- https://doi.org/10.1093/ejcts/ezaa128
Abstract
OBJECTIVES: The introduction and expansion of thoracic endovascular aortic repair (TEVAR) have revolutionized the treatment of a variety of thoracic aortic diseases. We sought to evaluate the incidence, causes, predictors and costs associated with 30-day readmission after TEVAR in a nationally representative cohort. METHODS: Adult patients undergoing isolated TEVAR were identified in the National Readmissions Database from 2010 to 2014. Hospital costs were estimated by converting individual hospital charge data adjusted to 2014 consumer price indices. Multivariable logistic regression was utilized to determine hospital- and patient-level factors associated with readmissions. RESULTS: A total of 24 983 TEVARs were noted during the study period; the average age of the patients was 65 +/- 16 years; 40% were women. The most common indication was an intact thoracic aneurysm (43.5%), followed by aortic dissection (30.5%). The average cost of the index admission was $63 644 +/- $52 312; the average hospital stay was 11 +/- 14 days; the index mortality rate was 6.7%. Readmissions within 30 days occurred in 17.4% of patients. Indications for readmission were varied; the most common aetiologies were cardiac (17.8%), infectious (16.0%) and pulmonary (12.1%). On multivariable analysis, the strongest predictor of readmission was the diagnosis, with a ruptured thoraco-abdominal aneurysm having the highest readmission burden (adjusted odds ratio 2.23, 1.17-4.24; P = 0.015). Notably, hospital volume did not predict index hospital length of stay, costs or 30-day readmissions (all P > 0.10). CONCLUSIONS: Annual TEVAR volume was not associated with any of the outcomes assessed. Rather, indication for TEVAR was the strongest predictor for many outcomes. As TEVAR becomes increasingly utilized, a focus on cardiac and vascular diseases may reduce readmissions and improve quality of care.Keywords
This publication has 27 references indexed in Scilit:
- Long-term comparison of thoracic endovascular aortic repair (TEVAR) to open surgery for the treatment of thoracic aortic aneurysmsThe Journal of Thoracic and Cardiovascular Surgery, 2012
- Midterm Cost and Effectiveness of Thoracic Endovascular Aortic Repair Versus Open RepairThe Annals of Thoracic Surgery, 2012
- Survival After Open Versus Endovascular Thoracic Aortic Aneurysm Repair in an Observational Study of the Medicare PopulationCirculation, 2011
- Thoracic endovascular repair versus open surgical repair — which is the more cost-effective intervention for descending thoracic aortic pathologies??European Journal of Cardio-Thoracic Surgery, 2011
- Superior nationwide outcomes of endovascular versus open repair for isolated descending thoracic aortic aneurysm in 11,669 patientsThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Randomized Comparison of Strategies for Type B Aortic DissectionCirculation, 2009
- A population-based analysis of endovascular versus open thoracic aortic aneurysm repairJournal of Vascular Surgery, 2009
- Modeling Length of Stay in Hospital and Other Right Skewed Data: Comparison of Phase-Type, Gamma and Log-Normal DistributionsValue in Health, 2009
- Endovascular treatment of thoracic aortic aneurysms: Results of the phase II multicenter trial of the GORE TAG thoracic endoprosthesisJournal of Vascular Surgery, 2005
- Emergency Endovascular Stent-Grafting for Life-Threatening Acute Type B Aortic DissectionsThe Annals of Thoracic Surgery, 2004